SCHEMBL26148008

SCHEMBL26148008

O=C(O)CCCCOc1cccc2c1C(O)N(C1CCC(=O)NC1=O)C2=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 16/20 0.52
▸ DDB1 Q16531 10/20 0.52
▸ IKZF3 Q9UKT9 4/20 0.44
▸ STAT3 P40763 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ CCNK O75909 1/20 0.39
▸ CDK12 Q9NYV4 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ CDK5 Q00535 1/20 0.39
▸ TNF P01375 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30241739 1.00 CRBN (0.52) CRBNDDB1IKZF3STAT3ALDH1A1
SCHEMBL18493738 0.88 CRBN (0.66) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22276598 0.83 CRBN (0.52) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL19709449 0.82 CRBN (0.52) CRBNDDB1IKZF3STAT3ALDH1A1
SCHEMBL30275753 0.81 CRBN (0.78) CRBNDDB1IKZF3STAT3ALDH1A1
SCHEMBL19692300 0.81 CRBN (0.78) CRBNDDB1IKZF3STAT3ALDH1A1
SCHEMBL23832857 0.80 CRBN (0.77) CRBNDDB1IKZF3STAT3CCNK
SCHEMBL22959658 0.80 CRBN (0.77) CRBNDDB1IKZF3STAT3CCNK
SCHEMBL21294522 0.80 CRBN (0.77) CRBNDDB1IKZF3STAT3CCNK
SCHEMBL22962804 0.80 CRBN (0.69) CRBNDDB1IKZF3TNFHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150974-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 — — US disclosed
US-20230150974-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 — — US disclosed
CN-115666575-A Compound and use thereof 福宏治疗公司 2023-01-31 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150974-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB CRBN 179/4885DDB1 987/4885IKZF3 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback